Connect with us


Cuba to see record-high foreign tourists in 2015



Havana: Cuba is expected to see a record high of foreign visitors this year as three million people have already visited the island nation so far, according to official figures.

By the end of this year, the total number of foreign visitors is set to break the record in 2014, when 30,02,745 foreigners visited, as per reported.

Canada remains the leading source country of tourists to Cuba, with more than 1.11 million visitors, followed by the European countries of Germany, England, France and Spain, said the tourism ministry on Monday.

At the same time, the country saw an increase of 20 percent in the number of visitors from Latin America, it said.

“The promising situation is due to Cuba’s dedication to improve the quality of products and services, supported by the government’s decision to promote the tourism industry,” according to the ministry.

Tourism is Cuba’s second-largest earner of foreign exchange, reaping over $2.6 billion a year.


UK approves Pfizer-BioNTech COVID-19 vaccine



Britain on Wednesday approved the Pfizer-BioNTech Covid-19 vaccine on independent advice of its medicines regulator.
The vaccine will be made available across the UK from next week.
“The Government has today accepted the recommendation from the independent Medicines and Healthcare products Regulatory Agency (MHRA) to approve Pfizer-BioNTech’s Covid-19 vaccine for use,” a UK Department of Health and Social Care spokesperson said in a statement.

Experts at the MHRA have concluded that the vaccine has met its strict standards of safety, quality and effectiveness after months of rigorous clinical trials and a thorough analysis of the data.
Care home residents, health and care staff, the elderly and the clinically extremely vulnerable will receive the vaccine on priority basis.
“The Joint Committee on Vaccinations and Immunisations (JCVI) will shortly publish its final advice for the priority groups to receive the vaccine,” the spokesperson said.

Continue Reading